ulcerative-colitis

Documents about ulcerative-colitis

• R-3750 in Patients With Mild to Moderate Ulcerative Colitis#908869ClinicalTrials.gov
• The Role of CALLY and HAALP in Ulcerative Colitis#878644ClinicalTrials.gov
• To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis#827760ClinicalTrials.gov
• Combination of Diet and Oral Budesonide for Ulcerative Colitis#908040ClinicalTrials.gov
• Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis#979068ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of AJM300 in Participants With Active Ulcerative Colitis#835273ClinicalTrials.gov
• Basiliximab Maintenance in Ulcerative Colitis#886323ClinicalTrials.gov
• Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.#909836ClinicalTrials.gov
• VE202 in Patients With Mild-to-Moderate Ulcerative Colitis#869877ClinicalTrials.gov
• Evaluation of Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of Bertilimumab in Patients With Active Moderate to Severe Ulcerative Colitis#841466ClinicalTrials.gov
• Antibiotics for the Treatment of Ulcerative Colitis#238141ClinicalTrials.gov
• Rupatadine in Patients With Ulcerative Colitis#903164ClinicalTrials.gov
• A Study of MDX-1100 in Subjects With Active Ulcerative Colitis#852440ClinicalTrials.gov
• Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis#967335ClinicalTrials.gov
• Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound#867392ClinicalTrials.gov
• Progression of Damage in Ulcerative Colitis#857825ClinicalTrials.gov
• Fecal Microbiota Transplantation for Ulcerative Colitis#900315ClinicalTrials.gov
• Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative Colitis#855895ClinicalTrials.gov
• A Trial of Rosiglitazone for Ulcerative Colitis#67778ClinicalTrials.gov
• Microbiome-targeted Diet Therapy in Ulcerative Colitis#832189ClinicalTrials.gov
• Open-label Extension Study of Brazikumab in Ulcerative Colitis#845767ClinicalTrials.gov
• Clinical Outcome of Treatment of Ulcerative Colitis in Adult#847025ClinicalTrials.gov
• Vitamin D and Disease Activity in Ulcerative Colitis#870252ClinicalTrials.gov
• Mind-Body Medicine and Ulcerative Colitis#906634ClinicalTrials.gov
• A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis#830169ClinicalTrials.gov
• Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis#860974ClinicalTrials.gov
• A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.#879209ClinicalTrials.gov
• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis#993203ClinicalTrials.gov
• Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients#832060ClinicalTrials.gov
• Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis#850267ClinicalTrials.gov
• Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission#865172ClinicalTrials.gov
• Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis#870165ClinicalTrials.gov
• Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis#879466ClinicalTrials.gov
• Superdonor FMT in Patients With Ulcerative Colitis#880601ClinicalTrials.gov
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis#840466ClinicalTrials.gov
• In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis#885949ClinicalTrials.gov
• Determination of the Optimal Treatment Target in Ulcerative Colitis#906163ClinicalTrials.gov
• Curcumin in Pediatric Ulcerative Colitis#917908ClinicalTrials.gov
• An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis#832965ClinicalTrials.gov
• A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis#858029ClinicalTrials.gov
• Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression#905713ClinicalTrials.gov
• Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis#848237ClinicalTrials.gov
• Microbiota and Probiotic Therapy in Ulcerative Colitis Patients#805643ClinicalTrials.gov
• Reduced Sulfur Diet in Ulcerative Colitis Patients#836647ClinicalTrials.gov
• Ulcerative Colitis and Vitamin D Supplementation#865106ClinicalTrials.gov
• Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis#899465ClinicalTrials.gov
• Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis#915441ClinicalTrials.gov
• Randomized-controlled Trial of Yoga for Ulcerative Colitis#992943ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis#812370ClinicalTrials.gov
• Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis#843261ClinicalTrials.gov